A
Ambit Biosciences
Develops small molecule kinase inhibitors for cancer and inflammatory disease treatments
About Ambit Biosciences
Ambit Canadian Pharmacy, accessible via ambitbio.com, is an online drugstore specializing in a broad spectrum of medications at competitive prices, coupled with high-quality service. The company primarily focuses on providing treatments for erectile dysfunction, depression, asthma, diabetes, and other serious health conditions. Ambit Canadian Pharmacy operates within the online pharmaceutical market, a rapidly growing sector due to the convenience and cost-effectiveness it offers to consumers.
Read full description
The business serves a diverse clientele, including individuals seeking affordable and accessible medication options without the need to visit a physical pharmacy. This includes patients with chronic conditions, those in need of specialized treatments, and individuals looking for over-the-counter solutions. The company’s business model revolves around eCommerce, where customers can browse, order, and receive medications directly to their doorstep. This model not only enhances customer convenience but also reduces overhead costs, allowing Ambit Canadian Pharmacy to offer lower prices compared to traditional brick-and-mortar pharmacies.
Revenue generation for Ambit Canadian Pharmacy comes from the sale of prescription and over-the-counter medications. By maintaining a wide range of products and leveraging the efficiency of online sales, the company maximizes its market reach and profitability. Additionally, the company emphasizes professionalism, reliability, and friendly service, which helps in building customer loyalty and repeat business.
In summary, Ambit Canadian Pharmacy is a key player in the online pharmaceutical market, providing essential medications at affordable prices with a focus on customer service and convenience.
At a glance
- Status
- Acquired
- Founded
- 2000
- Headquarters
- San Diego, United States
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 25.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Sep 2008
- Capital deployed
- $1.5M
- Preferred round
- SERIES A
Latest news
Press, funding announcements and product moves mentioning Ambit Biosciences.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2014 | $410M | $410M | Daiichi Sankyo | — |
| IPOOther financing | May 2013 | $65M | $142M | Undisclosed | — |
Growth signals
Latest recorded traffic for Ambit Biosciences is 1.6K monthly website visits, up 23.1% over the last three months. Ambit Biosciences's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- FVForward Ventures
- PFPerseus-Soros Biopharmaceutical Fund
Avalon Ventures
Series B and later13 investors entered at this stage
Gimv
Roche Venture Fund
GeneChem
Apposite Capital
Radius Ventures
Horizon Technology Finance Corporation
MedImmune Ventures
NovaQuest Capital Management
OrbiMed
Radius- GWGrowth Works
Aisling Capital
Forward Venture Capital
Other known investors1 additional known investor
Daiichi Sankyo
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ambit Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ambit Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








